<DOC>
	<DOCNO>NCT01119781</DOCNO>
	<brief_summary>The primary objective study evaluate pharmacokinetics ( PK ) single dose PEGylated Interferon Beta-1a ( BIIB017 ) administer subcutaneous participant renal impairment participant normal renal function ( healthy participant ) . A secondary objective study study population evaluate safety tolerability single dose PEGylated Interferon Beta-1a administer subcutaneous .</brief_summary>
	<brief_title>A Single-Dose , Pharmacokinetic/Pharmacodynamic ( PK/PD ) , &amp; Safety Study BIIB017 Participants With Renal Impairment &amp; Healthy Volunteers</brief_title>
	<detailed_description>This study open-label , multicenter , non-randomized , serial-group study estimate effect renal impairment BIIB017 PK/PD . The study conduct approximately 3 site US enroll approximately 35 participant : 6 healthy volunteer ( normal renal function ) , 9 mild renal impairment , 6 moderate renal impairment , 8 severe renal impairment , 6 participant end stage renal disease require hemodialysis 2 3 time week .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Interferon-beta</mesh_term>
	<criteria>Key Subjects must stable renal disease ( i.e. , change disease status within last month ) determine Investigator laboratory clinical finding support diagnosis renal impairment . Must body mass index ( BMI ) 18 35 kg/m2 inclusive . Key History clinically unstable ( past 6 month prior screen ) cardiac , endocrinologic , hematologic , hepatic , immunologic , metabolic , urologic , pulmonary , neurologic , dermatologic , psychiatric , major disease determine Investigator . Any evidence clinically significant finding screen evaluation , , opinion Investigator would pose safety risk , would interfere appropriate interpretation safety PK data , unspecified reason , opinion Investigator Biogen Idec , make subject unsuitable enrollment NOTE : Other protocol define Inclusion/Exclusion Criteria May Apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>